Brooklyn Investment Group increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 8.0% during the third quarter, HoldingsChannel reports. The fund owned 2,816 shares of the medical equipment provider’s stock after buying an additional 208 shares during the quarter. Brooklyn Investment Group’s holdings in Intuitive Surgical were worth $1,383,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at $558,807,000. International Assets Investment Management LLC boosted its position in shares of Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after purchasing an additional 1,088,415 shares in the last quarter. FMR LLC grew its stake in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the period. Strategic Financial Concepts LLC lifted its stake in Intuitive Surgical by 40,221.4% in the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after buying an additional 265,461 shares during the period. Finally, Manning & Napier Advisors LLC acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $91,466,000. 83.64% of the stock is currently owned by institutional investors.
Intuitive Surgical Stock Up 0.5 %
Shares of NASDAQ ISRG opened at $539.46 on Tuesday. The firm has a market cap of $192.14 billion, a P/E ratio of 86.26, a PEG ratio of 5.39 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $304.50 and a twelve month high of $552.00. The company has a 50 day moving average of $505.63 and a 200 day moving average of $465.19.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on ISRG shares. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price target for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $524.61.
Check Out Our Latest Stock Analysis on Intuitive Surgical
Insider Activity at Intuitive Surgical
In other news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total value of $90,655.48. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,655,048.26. The trade was a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,539 shares of company stock worth $26,112,364. 0.80% of the stock is owned by company insiders.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- Dividend Payout Ratio Calculator
- 3 Stocks That Authorized $1 Billion Stock Buybacks to Boost Value
- When to Sell a Stock for Profit or Loss
- Pure Storage’s GenAI Pods and AI Trends Could Spark Recovery
- Why Are These Companies Considered Blue Chips?
- Is Seaboard Corporation a Thanksgiving Feast for Investors?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.